Artificial Intelligence in Surveillance, Diagnosis, Drug Discovery and Vaccine Development against COVID-19
Abstract As of August 6th, 2021, the World Health Organization has notified 200.8 million laboratory-confirmed infections and 4.26 million deaths from COVID-19, making it the worst pandemic since the 1918 flu. The main challenges in mitigating COVID-19 are effective vaccination, treatment, and agile containment strategies. In this review, we focus on the potential of Artificial Intelligence (AI) in COVID-19 surveillance, diagnosis, outcome prediction, drug discovery and vaccine development. With the help of big data, AI tries to mimic the cognitive capabilities of a human brain, such as problem-solving and learning abilities. Machine Learning (ML), a subset of AI, holds special promise for solving problems based on experiences gained from the curated data. Advances in AI methods have created an unprecedented opportunity for building agile surveillance systems using the deluge of real-time data generated within a short span of time. During the COVID-19 pandemic, many reports have discussed the utility of AI approaches in prioritization, delivery, surveillance, and supply chain of drugs, vaccines, and non-pharmaceutical interventions. This review will discuss the clinical utility of AI-based models and will also discuss limitations and challenges faced by AI systems, such as model generalizability, explainability, and trust as pillars for real-life deployment in healthcare. Keywords: COVID-19; SARS-CoV-2; artificial intelligence; diagnosis; drug discovery; machine learning; pandemic; prediction; surveillance; vaccine.
Conflict of interest statement The authors declare no conflict of interest.
Figures Figure 1 The application of Artificial Intelligence… Figure 2 The role of AI tools…
Similar articles
Exploring the Potential of Artificial Intelligence and Machine Learning to Combat COVID-19 and Existing Opportunities for LMIC: A Scoping Review.Naseem M, et al. J Prim Care Community Health. 2020. PMID: 32996368 Free PMC article. Review.
Application of Big Data and Artificial Intelligence in COVID-19 Prevention, Diagnosis, Treatment and Management Decisions in China.Dong J, et al. J Med Syst. 2021. PMID: 34302549 Free PMC article. Review.
Leveraging Artificial Intelligence (AI) Capabilities for COVID-19 Containment.Surianarayanan C, et al. New Gener Comput. 2021. PMID: 34131359 Free PMC article.
Application of artificial intelligence and machine learning for COVID-19 drug discovery and vaccine design.Lv H, et al. Brief Bioinform. 2021. PMID: 34410360
COVID-19 in the Age of Artificial Intelligence: A Comprehensive Review.Rasheed J, et al. Interdiscip Sci. 2021. PMID: 33886097 Free PMC article. Review.
References
WHO Coronavirus (COVID-19) Dashboard. [(accessed on 7 August 2021)]; Available online: https://covid19.who.int/
Gavas M., Pleeck S. Center for Global Development; 2021. [(accessed on 7 August 2021)]. Global Trends in 2021: How COVID-19 Is Transforming International Development; pp. 1–16. Available online: https://www.cgdev.org/publication/global-trends-2021-how-Covid-transform....
Fenizia C., Biasin M., Cetin I., Vergani P., Mileto D., Spinillo A., Gismondo M.R., Perotti F., Callegari C., Mancon A., et al. Analysis of SARS-CoV-2 vertical transmission during pregnancy. Nat. Commun. 2020;11:5128. doi: 10.1038/s41467-020-18933-4. - DOI - PMC - PubMed
Greenhalgh T., Jimenez J.L., Prather K.A., Tufekci Z., Fisman D., Schooley R. Ten scientific reasons in support of airborne transmission of SARS-CoV-2. Lancet. 2021;397:1603–1605. doi: 10.1016/S0140-6736(21)00869-2. - DOI - PMC - PubMed
Sia S.F., Yan L.-M., Chin A.W.H., Fung K., Choy K.-T., Wong A.Y.L., Kaewpreedee P., Perera R.A.P.M., Poon L.L.M., Nicholls J.M., et al. Pathogenesis and transmission of SARS-CoV-2 in golden hamsters. Nature. 2020;583:834–838. doi: 10.1038/s41586-020-2342-5. - DOI - PMC - PubMed
Comentarios